NEIM-08 A PHASE II STUDY OF MULTIPARAMETRIC MR-GUIDED HIGH DOSE ADAPTIVE RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: Biologically-informed radiotherapy (RT) targeting an adversely prognostic hypercellular/hyperperfused imaging phenotype in patients with newly diagnosed glioblastoma (GBM) may improve outcomes by identifying emerging regions of treatment resistance associated with survival (OS), and is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Michelle, Aryal, Madhava, Rosen, Benjamin, Parmar, Hemant, You, Daekeun, Junck, Larry, Leung, Denise, Umemura, Yoshie, Heth, Jason, Al-Holou, Wajd, Hollon, Todd, Wahl, Daniel, Lawrence, Theodore, Cao, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354211/
http://dx.doi.org/10.1093/noajnl/vdac078.075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354211/
http://dx.doi.org/10.1093/noajnl/vdac078.075

Ejemplares similares